Lataa...
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients experiencing the common...
Tallennettuna:
| Julkaisussa: | Neural Regen Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749469/ https://ncbi.nlm.nih.gov/pubmed/32594033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.284981 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|